UPDATE: Raymond James Upgrades Arcturus Therapeutics (ARCT) to Market Perform
Tweet Send to a Friend
(Updated - January 31, 2022 6:27 AM EST)
Raymond James analyst Steven Seedhouse upgraded Arcturus Therapeutics (NASDAQ: ARCT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Raymond James analyst Steven Seedhouse upgraded Arcturus Therapeutics (NASDAQ: ARCT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
